Search for: "Par Pharmaceutical, Inc." Results 21 - 40 of 146
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Mar 2018, 1:34 pm by Pierre T. Nguyen
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]
18 Jan 2018, 9:34 am by m zamora
WARNING LETTERMark BaumImprimis Pharmaceuticals Inc.12264 El Camino Real, Suite 350San Diego, CA 92130Dear Mr. [read post]
1 Nov 2017, 4:00 am by Administrator
TD Canada Trust, 2017 SCC 51 [1] A pharmaceutical company was the victim of a fraudulent cheque scheme implemented by one of its employees. [read post]
29 Sep 2017, 12:26 pm by Adam Weinstein
  IPOs and offerings of small pharmaceutical companies are incredibly risky – on par with the risks of penny stocks. [read post]
8 Nov 2016, 11:53 pm by Kevin LaCroix
Actavis acquired Allergan, Inc. in June 2015 and the merged company took Allergan’s name. [read post]
26 Jan 2016, 11:23 am by Lawrence B. Ebert
**As one small footnote, Ampyra is not a disease-modifying treatment for MS, in contrast to Copaxone or Tecfidera.link to BNA report: http://www.bna.com/acorda-par-settle-n57982066522/ [read post]
20 May 2015, 1:00 am by Paul Caron
Wall Street Journal, Rules Fail To Rein In Tax-Driven Takeovers: Endo International PLC agreed to buy rival drug maker Par Pharmaceutical Holdings Inc. for $8 billion, the latest in a string of cross-border mergers steering tax revenue away from the U.S., despite Washington’s efforts. [read post]
16 Feb 2015, 1:44 am
  * "Fool's errand": no need to create your own brand if you can use someone else's Jeremy notes Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH [2015] EWCA Civ 54 [on which see earlier katpost here], a trade mark infringement decision of the Court of Appeal, England and Wales, on parallel importation and over-stickering of pharmaceutical products. [read post]